Chongqing Pharscin Pharmaceutical Co., Ltd.

XSEC:002907 Stock Report

Market Cap: CN¥5.6b

Chongqing Pharscin Pharmaceutical Balance Sheet Health

Financial Health criteria checks 6/6

Chongqing Pharscin Pharmaceutical has a total shareholder equity of CN¥1.7B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥1.9B and CN¥254.4M respectively. Chongqing Pharscin Pharmaceutical's EBIT is CN¥43.8M making its interest coverage ratio -3.7. It has cash and short-term investments of CN¥471.9M.

Key information

0%

Debt to equity ratio

CN¥0

Debt

Interest coverage ratio-3.7x
CashCN¥471.87m
EquityCN¥1.66b
Total liabilitiesCN¥254.44m
Total assetsCN¥1.91b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 002907's short term assets (CN¥1.0B) exceed its short term liabilities (CN¥207.5M).

Long Term Liabilities: 002907's short term assets (CN¥1.0B) exceed its long term liabilities (CN¥46.9M).


Debt to Equity History and Analysis

Debt Level: 002907 is debt free.

Reducing Debt: 002907 has no debt compared to 5 years ago when its debt to equity ratio was 20.9%.

Debt Coverage: 002907 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 002907 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies